50 results on '"Cao, Davide"'
Search Results
2. Aortic Valve-in-Valve Procedures: Challenges and Future Directions.
3. Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes.
4. Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials.
5. Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
6. Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review.
7. Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention.
8. Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study.
9. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.
10. Procedural embolic protection strategies for carotid artery stenting: current status and future prospects.
11. Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial.
12. New Insights into Pathophysiology and New Risk Factors for ACS.
13. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
14. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside.
15. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
16. From surgical clamping to endovascular flow arrest/reversal: the concept behind the system.
17. Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope.
18. Edge‐to‐edge percutaneous mitral repair for functional ischaemic and non‐ischaemic mitral regurgitation: a systematic review and meta‐analysis.
19. Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.
20. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
21. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
22. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
23. Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
24. Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
25. Impact of anemia on short‐term outcomes after TAVR: A subgroup analysis from the BRAVO‐3 randomized trial.
26. Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents.
27. Impact of sex on long‐term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
28. Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
29. Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria.
30. Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies.
31. Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials.
32. Prevalence and prognostic impact of hsCRP elevation are age‐dependent in women but not in men undergoing percutaneous coronary intervention.
33. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry.
34. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
35. First and recurrent events in the ISCHEMIA trial: two sides of the same coin.
36. Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review.
37. Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial.
38. Contrast-induced acute kidney injury.
39. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry.
40. Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.
41. Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy.
42. Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry.
43. On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach.
44. Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost.
45. Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
46. Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
47. Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention.
48. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation.
49. Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care?
50. Minding the Microcirculation: Is it Worth the Effort?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.